Largest health care biotech companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Amgen leads the 24 health care biotech companies ranked by total assets, at NOK 884.8B, ahead of Gilead Sciences (NOK 576.5B) and Biogen (NOK 287.6B). Figures as of 19 Nov 2026, 23:53 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- AmgenNOK 884.8B
- Median
- NOK 25B
- Combined market value
- NOK 8.09T
- Countries
- 5
Market values as of .
All countries▾
Health Care▾
Biotech▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | NOK 884.8B | NOK 2.32T | NOK 4,286.28 | 1.14% down | 32% up | ||
| 2 | Gilead SciencesGILD · Health Care | NOK 576.5B | NOK 2.02T | NOK 1,626.62 | 1.45% down | 35% up | ||
| 3 | BiogenBIIB · Health Care | NOK 287.6B | NOK 356.8B | NOK 2,413.90 | 1.70% down | 49% up | ||
| 4 | BioNTechBNTX · Health Care | NOK 238.3B | NOK 197.1B | NOK 794.90 | 2.26% down | 14% down | ||
| 5 | ModernaMRNA · Health Care | NOK 120.5B | NOK 787.8B | NOK 1,947.00 | 1.29% up | 780% up | ||
| 6 | argenxARGX · Health Care | NOK 84.8B | NOK 578.7B | NOK 9,201.59 | 0.08% up | 2% up | ||
| 7 | QiagenQGEN · Health Care | NOK 61.4B | NOK 100.1B | NOK 484.77 | 0.14% up | 9% up | ||
| 8 | Neurocrine BiosciencesNBIX · Health Care | NOK 45.2B | NOK 154.8B | NOK 1,529.53 | 3.85% down | 17% up | ||
| 9 | VaxcytePCVX · Health Care | NOK 29.3B | NOK 90.2B | NOK 570.04 | 0.27% down | 23% up | ||
| 10 | RepligenRGEN · Health Care | NOK 28.8B | NOK 106.3B | NOK 1,663.35 | 1.38% down | 12% up | ||
| 11 | ExelixisEXEL · Health Care | NOK 27.8B | NOK 156.9B | NOK 643.01 | 3.60% down | 63% up | ||
| 12 | Bio-TechneTECH · Health Care | NOK 25.3B | NOK 111.6B | NOK 710.11 | 0.07% down | 24% up | ||
| 13 | Halozyme TherapeuticsHALO · Health Care | NOK 24.7B | NOK 103.6B | NOK 908.79 | 2.88% down | 39% up | ||
| 14 | Revolution MedicinesRVMD · Health Care | NOK 23B | NOK 336.8B | NOK 1,557.27 | 0.24% down | 129% up | ||
| 15 | CRISPR TherapeuticsCRSP · Health Care | NOK 22.1B | NOK 36.9B | NOK 380.26 | 3.14% down | 18% down | ||
| 16 | Kymera TherapeuticsKYMR · Health Care | NOK 17B | NOK 99.6B | NOK 1,166.17 | 1.44% down | 87% up | ||
| 17 | Krystal BiotechKRYS · Health Care | NOK 13B | NOK 91.4B | NOK 3,084.84 | 0.15% up | 54% up | ||
| 18 | ImmunovantIMVT · Health Care | NOK 9.3B | NOK 65.7B | NOK 317.65 | 1.96% down | 46% up | ||
| 19 | CG OncologyCGON · Health Care | NOK 7.7B | NOK 71.5B | NOK 799.98 | 2.38% up | 97% up | ||
| 20 | Twist BioscienceTWST · Health Care | NOK 6.3B | NOK 74.3B | NOK 1,090.27 | 4.07% down | 346% up | ||
| 21 | Adaptive BiotechnologiesADPT · Health Care | NOK 5B | NOK 44.4B | NOK 273.98 | 1.44% down | 74% up | ||
| 22 | ImmunityBioIBRX · Health Care | NOK 4.9B | NOK 68.3B | NOK 64.17 | 1.94% down | 232% up | ||
| 23 | Scholar Rock HoldingSRRK · Health Care | NOK 3.9B | NOK 60B | NOK 492.00 | 4.94% up | 26% up | ||
| 24 | Kodiak SciencesKOD · Health Care | NOK 3.4B | NOK 62.5B | NOK 956.26 | 0.09% up | 399% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7677 NOK).
Questions and answers
Which health care biotech companies rank first by total assets?
Amgen (NOK 884.8B), Gilead Sciences (NOK 576.5B) and Biogen (NOK 287.6B) are the top three of the 24 health care biotech companies ranked by total assets as of 19 Nov 2026, 23:53 UTC.
How many health care biotech companies are in this ranking?
24 are ranked by total assets.
What are these health care biotech companies worth together?
The 24 health care biotech companies ranked by total assets have a combined market value of NOK 8.09T as of 19 Nov 2026, 23:53 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care biotech companies by total assets”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.